These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10952323)

  • 1. Improved blood cellular biocompatibility with heparin coated circuits during cardiopulmonary bypass.
    Belboul A; Akbar O; Löfgren C; Jungbeck M; Storm C; Roberts A
    J Cardiovasc Surg (Torino); 2000 Jun; 41(3):357-62. PubMed ID: 10952323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of heparin-coated and uncoated extracorporeal circuits on blood rheology during cardiac surgery.
    Belboul A; Al-Khaja N; Gudmundsson M; Karlsson H; Uchino T; Liu B; El-Gatit A; Bjell A; Roberts D; William-Olsson G
    J Extra Corpor Technol; 1993; 25(2):40-6. PubMed ID: 10148847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
    Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
    Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations.
    te Velthuis H; Baufreton C; Jansen PG; Thijs CM; Hack CE; Sturk A; Wildevuur CR; Loisance DY
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):117-22. PubMed ID: 9240301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating.
    Seeburger J; Hoffmann J; Wendel HP; Ziemer G; Aebert H
    Circulation; 2005 Aug; 112(9 Suppl):I224-8. PubMed ID: 16159821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting.
    Øvrum E; Tangen G; Tølløfsrud S; Skeie B; Ringdal MA; Istad R; Øystese R
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1145-9. PubMed ID: 20709334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.
    Kreisler KR; Vance RA; Cruzzavala J; Mahnken JD
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):608-11. PubMed ID: 16202894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of poly(2-methoxyethylacrylate) in primary coronary artery bypass grafting.
    Vang SN; Brady CP; Christensen KA; Isler JR; Allen KR
    J Extra Corpor Technol; 2005 Mar; 37(1):23-31. PubMed ID: 15804153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Duraflo II heparin-coated cardiopulmonary bypass circuits on the coagulation system, endothelial damage, and cytokine release in patients with cardiac operation employing aprotinin and steroids.
    Inui K; Shimazaki Y; Watanabe T; Takahashi T; Minowa T; Takeda H; Yanagawa N; Sotoda Y
    Artif Organs; 1999 Dec; 23(12):1107-12. PubMed ID: 10619929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
    Mirow N; Brinkmann T; Minami K; Tenderich G; Schulte-Eistrup S; Kleesiek K; Körfer R
    J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E; Am Holen E; Tangen G; Ringdal MA
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-coated cardiopulmonary bypass circuit: clinical effects in pediatric cardiac surgery.
    Miyaji K; Hannan RL; Ojito J; Jacobs JP; White JA; Burke RP
    J Card Surg; 2000; 15(3):194-8. PubMed ID: 11414605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.